Learn more

BIOINFRA INC

Overview
  • Total Patents
    47
  • GoodIP Patent Rank
    205,712
  • Filing trend
    ⇩ 100.0%
About

BIOINFRA INC has a total of 47 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2002. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets measurement, computer technology and biotechnology are VIRCO NV, COYNE IP HOLDINGS LLC and CT HOSPITALIER UNIVERSITAIRE MONTPELLIER.

Patent filings per year

Chart showing BIOINFRA INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Kim Chul Woo 44
#2 Shin Yong Sung 18
#3 Park Pil Je 15
#4 Jang Ji Young 14
#5 Kang Kyung Nam 14
#6 Kim Yong Dai 10
#7 Oh Mi Ae 8
#8 Kim Joung Youn 8
#9 Shin Ho Sang 7
#10 Ohn Syng-Yup 6

Latest patents

Publication Filing date Title
KR20150086442A Composition for overcoming resistance to her2 inhibitor comprising ant2 sirna
KR20150069056A Smart cancer-screening service and system by way of automation flatform installed in smart phones
KR101384686B1 Method of predicting responsiveness of lung cancer treatment to egfr targeting agent
KR20130054311A Lung cancer diagnosis kit using combined biomarkers
KR20140088996A Diagnosis and screening method of disseminated intravascular coagulation based upon des-r prothrombin activation peptide fragment f2
KR20130004204A Method on composing combined biomarkers for lung cancer diagnosis
KR20130004203A Combined biomarkers information processing method for lung cancer diagnosis
WO2012091506A2 Composite biomarker for the diagnosis of lung cancer, and lung cancer diagnosis method using same
KR20130022204A Method of using ant2 mrna in exosome for breast cancer diagnosis
KR20130015413A Early diagnostic method of gestational diabetes, apolipoprotein c3 as a biomarker for the diagnosis of gestational diabetes, apolipoprotein c3 for the diagnosis of gestational diabetes and how to use it as a biomarker, information processing method for early diagnosis of gestational diabetes, monitoring for gestational diabetes, kit for diagnosis and screening
KR20130015414A Early diagnostic method of gestational diabetes, apolipoprotein c3 as a biomarker for the diagnosis of gestational diabetes, method to use apolipoprotein c3 as a biomarker, and information processing method for early diagnosis of gestational diabetes
KR20130014840A Method for treating and diagnosing liver cancer using mir-636
KR20130011379A Method for treating lung cancer using expression or activity inhibitors of adenine nucleotide translocator 2
KR20120116766A Method for treating liver cancer using expression or activity inhibitors of adenine nucleotide translocator 2
KR20120095263A Method for treating breast cancer by decreasing the expression of adenine nucleotide translocator 2 mrna
KR20120077570A Combined biomarkers, their comprising method, diagnostic method and system using them for lung cancer
KR20120077569A Combined biomarkers, method on composing combined biomarkers, and kit for for lung cancer diagnosis
KR20120077568A Cancer diagnosis method, cancer diagnosis model building method, cancer diagnosis system using combined biomarkers and method on measuring effect of each biomarker
KR20120077567A Combined biomarkers, information processing method, and kit for for lung cancer diagnosis
KR20090121259A Protein markers for diagnosis and screening and the method of mesurement thereof for colon cancer diagnosis